Immunometabolic Modulatory Role of Naltrexone in BV-2 Microglia Cells

Int J Mol Sci
05 Aug 2021
https://pubmed.ncbi.nlm.nih.gov/34445130/

Dr Richard Nahas, LDN Radio Show 12 April 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Richard Nahas shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Kat Toups, LDN Radio Show 15 March 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr. Kat Toups is an MD from California in the US,  a functional medicine doctor and a psychiatrist.

Dr John Kim, LDN Radio Show 07 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we're joined by Dr John Kim. Thank you for joining us, John.

Dr John Kim: Well, thank you for the invitation, Linda,

Complex Regional Pain Syndrome: A Comprehensive Review 

Pain Ther
24 June 2021
https://pubmed.ncbi.nlm.nih.gov/34165690/

Low-Dose Naltrexone Use for Patients with Chronic Regional Pain Syndrome: A Systematic Literature Review

Pain Physician
July 2021
https://pubmed.ncbi.nlm.nih.gov/34213865/

Background: Complex regional pain syndrome is a rare, neuropathic disorder that affects fewer than 200,000 individuals in the United States annually. Current treatments often focus on pain management and fall short of relieving symptoms of pain and dystonia in patients.

Low-Dose Naltrexone May Be Opioid Replacement for Chronic Pain

Verywell Health
04 March 2021
https://www.verywellhealth.com/low-dose-naltrexone-may-be-opioid-replacement-for-chronic-pain-5115153

Treatment of Complex Regional Pain Syndrome (CRPS) Using Low Dose Naltrexone (LDN)

J Neuroimmune Pharmacol
June 2013
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661907/

No Antagonists for an Antagonist: One Pitfall of Chronic Oral Low-Dose Naltrexone

Pain Medicine
December 2015
http://www.painmedicinenews.com/download/Casespmnse1215_WM.pdf

A 48 year old man with 10 years of chronic abdominal pain following an open repair of an abdominal aortic aneurysm was treated with low dose naltrexone 1.5mg/day for 3 years with satisfactory results.

Low-Dose Naltrexone: A New Therapy Option for Complex Regional Pain Syndrome Type I Patients

Int J Pharm Compd
May-June 2016
https://www.ncbi.nlm.nih.gov/pubmed/28333660